vs

Side-by-side financial comparison of Red Cat Holdings, Inc. (RCAT) and Relay Therapeutics, Inc. (RLAY). Click either name above to swap in a different company.

Red Cat Holdings, Inc. is the larger business by last-quarter revenue ($9.6M vs $7.0M, roughly 1.4× Relay Therapeutics, Inc.). Red Cat Holdings, Inc. produced more free cash flow last quarter ($-24.5M vs $-235.9M).

Mega Cat Studios is an American video game development and publishing company located in Pittsburgh, Pennsylvania. It was founded in 2015 by James Deighan, Nick Mann, and Zack Manko.

Relay Therapeutics is a clinical-stage biotechnology company focused on developing precision oncology therapies. It leverages advanced computational modeling of protein dynamics, paired with cutting-edge experimental biology, to design targeted medicines for previously intractable cancer types, serving global oncology care markets and patient populations.

RCAT vs RLAY — Head-to-Head

Bigger by revenue
RCAT
RCAT
1.4× larger
RCAT
$9.6M
$7.0M
RLAY
More free cash flow
RCAT
RCAT
$211.3M more FCF
RCAT
$-24.5M
$-235.9M
RLAY

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
RCAT
RCAT
RLAY
RLAY
Revenue
$9.6M
$7.0M
Net Profit
$-16.0M
Gross Margin
6.6%
Operating Margin
-181.7%
Net Margin
-166.0%
Revenue YoY
988.2%
Net Profit YoY
-29.0%
EPS (diluted)
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RCAT
RCAT
RLAY
RLAY
Q4 25
$7.0M
Q3 25
$9.6M
$0
Q1 25
$1.6M
$7.7M
Q4 24
$0
$0
Q3 24
$0
Q2 24
$0
Q1 24
$5.8M
$10.0M
Q2 22
$1.3M
Net Profit
RCAT
RCAT
RLAY
RLAY
Q4 25
Q3 25
$-16.0M
$-74.1M
Q1 25
$-23.1M
$-77.1M
Q4 24
$-13.3M
Q3 24
$-88.1M
Q2 24
$-92.2M
Q1 24
$-5.5M
$-81.4M
Q2 22
$-4.8M
Gross Margin
RCAT
RCAT
RLAY
RLAY
Q4 25
Q3 25
6.6%
Q1 25
-52.2%
Q4 24
Q3 24
Q2 24
Q1 24
18.8%
Q2 22
25.2%
Operating Margin
RCAT
RCAT
RLAY
RLAY
Q4 25
Q3 25
-181.7%
Q1 25
-765.7%
-1105.2%
Q4 24
Q3 24
Q2 24
Q1 24
-76.0%
-903.0%
Q2 22
Net Margin
RCAT
RCAT
RLAY
RLAY
Q4 25
Q3 25
-166.0%
Q1 25
-1418.9%
-1003.6%
Q4 24
Q3 24
Q2 24
Q1 24
-93.9%
-813.3%
Q2 22
-367.8%
EPS (diluted)
RCAT
RCAT
RLAY
RLAY
Q4 25
Q3 25
$-0.16
$-0.43
Q1 25
$-0.27
$-0.46
Q4 24
Q3 24
$-0.63
Q2 24
$-0.69
Q1 24
$-0.62
Q2 22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RCAT
RCAT
RLAY
RLAY
Cash + ST InvestmentsLiquidity on hand
$84.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$253.3M
$567.1M
Total Assets
$286.0M
$621.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RCAT
RCAT
RLAY
RLAY
Q4 25
$84.0M
Q3 25
$91.6M
Q1 25
$93.5M
Q4 24
$124.3M
Q3 24
$152.4M
Q2 24
$134.1M
Q1 24
$152.9M
Q2 22
Stockholders' Equity
RCAT
RCAT
RLAY
RLAY
Q4 25
$567.1M
Q3 25
$253.3M
$607.7M
Q1 25
$28.9M
$721.1M
Q4 24
$27.0M
$777.8M
Q3 24
$838.9M
Q2 24
$681.7M
Q1 24
$49.6M
$745.8M
Q2 22
Total Assets
RCAT
RCAT
RLAY
RLAY
Q4 25
$621.3M
Q3 25
$286.0M
$670.0M
Q1 25
$59.7M
$799.4M
Q4 24
$51.1M
$871.3M
Q3 24
$930.1M
Q2 24
$772.5M
Q1 24
$55.3M
$841.4M
Q2 22
$85.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RCAT
RCAT
RLAY
RLAY
Operating Cash FlowLast quarter
$-23.9M
$-235.5M
Free Cash FlowOCF − Capex
$-24.5M
$-235.9M
FCF MarginFCF / Revenue
-254.2%
-3370.0%
Capex IntensityCapex / Revenue
6.9%
5.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-55.0M
$-622.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RCAT
RCAT
RLAY
RLAY
Q4 25
$-235.5M
Q3 25
$-23.9M
$-62.1M
Q1 25
$-15.9M
$-73.2M
Q4 24
$-10.1M
$-249.1M
Q3 24
$-75.1M
Q2 24
$-65.8M
Q1 24
$-4.1M
$-50.3M
Q2 22
$-4.0M
Free Cash Flow
RCAT
RCAT
RLAY
RLAY
Q4 25
$-235.9M
Q3 25
$-24.5M
$-62.1M
Q1 25
$-16.2M
$-73.6M
Q4 24
$-10.2M
$-251.1M
Q3 24
$-75.3M
Q2 24
$-65.8M
Q1 24
$-4.2M
$-52.1M
Q2 22
FCF Margin
RCAT
RCAT
RLAY
RLAY
Q4 25
-3370.0%
Q3 25
-254.2%
Q1 25
-992.9%
-958.4%
Q4 24
Q3 24
Q2 24
Q1 24
-71.1%
-520.7%
Q2 22
Capex Intensity
RCAT
RCAT
RLAY
RLAY
Q4 25
5.9%
Q3 25
6.9%
Q1 25
16.8%
5.0%
Q4 24
Q3 24
Q2 24
Q1 24
0.8%
17.8%
Q2 22

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RCAT
RCAT

Products$8.5M88%
Services$1.2M12%

RLAY
RLAY

Segment breakdown not available.

Related Comparisons